We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alliance in Immunohistochemical Testing

By HospiMedica staff writers
Posted on 31 Jan 2002
A collaboration to develop and market reagent kits and antibodies used in immunohistochemical (IHC) testing worldwide has been announced by ChromaVision Medical Systems, Inc. More...
(San Juan Capistrano, CA, USA) and Richard-Allan Scientific Company (Kalamazoo, MI, USA).

Richard-Allan will manufacture antibodies and reagents for ChromaVision to market along with its Automated Cellular Imaging System (ACIS), which combines color-based imaging technology with automated microscopy. The combination of specialized reagent kits and the ACIS digital microscope system will provide laboratory and pathology customers with an integrated laboratory testing tool to address the growing need for standardized, quantifiable IHC testing information. Reagent kits that support tests most frequently performed by customers on the ACIS system are expected to be available in the near future, followed by a full suite of kits that support all tests performed using the system.

"Richard-Allan Scientific is the worldwide leader in reagent, consumable, and equipment sales to the anatomical pathology market, while the ChromaVision ACIS has emerged as the most widely used imaging system in clinical practice,” said Carl W. Apfelbach, president and COO of ChromaVision. "This alliance provides a unique sales growth opportunity for both companies.”




Related Links:
Richard-Allan
ChromaVision

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.